Antagna on 15/07/2009Dokumentreferens: INT/472-EESC-2009-1191Opinion Type: RemissReferral: COM(2008) 668 final - 2008/0261 (COD)Official Journal: OJ C 317, 23.12.2009, p. 62 Rapporteur: Mr Peter Morgan (Employers - GR I / United Kingdom) Plenarsession: 455 - Jul 15, 2009 Jul 16, 2009 Related links Läkemedel EESK:s yttrande: Prevention of falsified medicinal productsbg cs da de el en es et fi fr hu it lt lv mt nl pl pt ro sk sl sv Related linksRelated links: PreLex - Monitoring of the decision-making process between institutionsPublication on Pharmaceuticals
